| Literature DB >> 34136201 |
Emad Molaei1, Ali Molaei2, Farshad Abedi1, A Wallace Hayes3, Gholamreza Karimi4,5.
Abstract
Nephropathy can occur following exposure of the kidneys to oxidative stress. Oxidative stress is the result of reactive oxygen species (ROS) formation due to intracellular catabolism or exogenous toxicant exposure. Many natural products (NPs) with antioxidant properties have been used to demonstrate that oxidative damage-induced nephrotoxicity can be ameliorated or at least reduced through stimulation of the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. Nrf2 is a basic leucine zipper (bZip) transcription factor that regulates gene expression of the antioxidant response elements (ARE). Nrf2 is involved in the cellular antioxidant-detoxification machinery. Nrf2 activation is a major mechanism of nephroprotective activity for these NPs, which facilitates its entry into the nucleus, primarily by inhibiting Kelch like-ECH-associated protein 1 (Keap1). The purpose of this article was to review the peer-reviewed literature of NPs that have shown mitigating effects on renal disorder by stimulating Nrf2 and thereby suggesting potential new therapeutic or prophylactic strategies against kidney-damaging xenobiotics.Entities:
Keywords: Nrf2; herbal medicine; natural products; nephroprotective; nephrotoxicity; xenobiotics
Year: 2021 PMID: 34136201 PMCID: PMC8194945 DOI: 10.1002/fsn3.2320
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
FIGURE 1Mechanisms of nephroprotective activity of natural products by activating Nrf2 pathway against xenobiotics cytotoxicity
Summary of useful NPs against nephrotoxicity of xenobiotics by activating Nrf2 pathway
| The herbal(s) or microorganism(s) | Type of extract | Bioactive compounds/dose/route | Class | Molecular tests | Nephrotoxic agent and dose/route | Study model | Sources of NPs | Ref. |
|---|---|---|---|---|---|---|---|---|
|
| Aqueous | 15 or 45 mg kg−1 day−1 for 12 months/oral | Polyphenol | Nrf2; NQO‐1; HO‐1; GST‐α1; SOD1; SOD2; SOD3; CAT; GPx |
Adriamycin 100 mg/kg/intraperitoneal | Sprague–Dawley rats | Herbal | (Espinosa et al., |
|
| Ethanolic | 2,3,5,40‐Tetrahydroxystilbene‐2‐O‐b‐D‐glucoside 2.5 and 10 mg kg−1 day−1 for 24 days/oral | Polyphenol | HO‐1; NQO‐1; Nrf2; FN; COL1A1; COL4A1; COL4A2; Podocin |
Adriamycin 10 mg/kg/intravenous | Balb/c mice | Herbal | (Lin, Bayarsengee, et al., |
|
| Aqueous |
Thymoquinone 50 mg kg−1 day−1 for 3 weeks/oral | Nrf2; GAPDH; MDA; SOD; GST; LPO; NOX4; TNF‐α; IL‐6; IL‐10 |
Adriamycin 3.5 mg/kg twice weekly/intraperitoneal | Sprague–Dawley rats | Herbal | (Elsherbiny & El‐Sherbiny, | |
|
| Ethanolic | 200 and 400 mg kg−1 day−1 for 7 days/oral | AOPP; H2O2; MDA; NO; MPO; NPT; PT; XO; TP urine; PC; SOD; GSH; GPx; GST |
Cisplatin 10 mg kg−1 day−1 for 7 days/intraperitoneal | Wistar rats | Herbal | (Adeoye et al., | |
|
|
Curcumin 100 mg/kg/oral for 5 days | Polyphenol | TNF‐α; IL‐6; MRP‐1; KIM‐1; Akt; Nrf2; HO‐1; Caspase‐3; NFƙB; SOD; CAT; GR; GPx |
Cisplatin 5 mg/kg/intraperitoneal | HEK 293 cell | Herbal | (Al Fayi et al., | |
|
|
Daphnetin 2.5, 5, 10 mg/kg/for 3 days/intraperitoneal | Coumarin | MDA;IL‐1β; TNF‐α; Nrf2; HO‐1; p‐NF‐κB p65; NF‐κB p65; p‐IκBα; IκBα; ROS |
Cisplatin 20 mg kg−1 day−1 for 4 days/intraperitoneal | C57BL/6 mice | Herbal | (L. Zhang, Gu, et al., | |
|
Dioscin 10, 20 and 40 mg kg−1 day−1 for 12 days/oral | Steroid saponin | MDA; SOD; GSH; GSH‐Px; miR‐34a; Nrf2; HO‐1; GCLC; GCLM; AP‐1; COX‐II; IκB‐α; HMGB1; NF‐κB; IL‐1β; IL‐6; TNF‐α; Sirt1; Keap1 |
Cisplatin 7 mg/kg/intraperitoneal | Wistar rats and Normal rat kidney epithelial cell | Herbal | (Y. M. Zhang et al., | ||
|
|
Embelin 25 and 50 mg kg−1 day−1 for 2 weeks/oral | Hydroxy benzoquinone | NF‐κB; IL‐1β; IL‐6; TNF‐α; Nrf2; HO‐1; GSH; GR; GST; CAT; SOD; MDA |
Cisplatin 5 mg/kg/intraperitoneal | Sprague–Dawley rats | Herbal | (Qin et al., | |
|
|
Farrerol 20 mg/kg/intraperitoneal | Cell viability; Nrf2; HO‐1; NQO‐1; Keap1; NOX4; p‐ JNK; T‐JNK; p‐ERK; T‐ERK; p‐p38; T‐p38; p‐ NF‐κB; p‐p65; NLRP3; p‐p53; p53; Bcl‐2; Bax; Caspase‐3 |
Cisplatin 20 mg/kg/intraperitoneal | C57BL/6 Mice and Mouse tubular epithelial cells (MTECs) and human proximal tubule cells (HK‐2) | Herbal | (Ma et al., | ||
|
| Methanolic |
6‐Hydroxy‐1‐methylindole‐3‐acetonitrile 25, 50, or 100 μM for 3 hr/oral | Creatinine; LDH; Nrf2; HO‐1; SOD; CAT; GR; H2O2; MDA; GSH |
Cisplatin 50 mM For 6 hr/intraperitoneal | Renal epithelial cell line derived from the porcine kidney | Herbal | (Moon et al., | |
|
|
Isoorientin 50 mg/kg for 3 days/intraperitoneal | Flavone | Cell viability; Sirt1; Sirt6; Nrf2; HO‐1; NQO‐1; Keap1; NOX4; p‐ JNK; T‐JNK; p‐ERK; T‐ERK; p‐p38; T‐p38; p‐NF‐κB; p‐p65; NLRP3; p‐p53; p53; Bcl‐2; Bax; Caspase‐3; MPO; MDA; SOD; GSH |
Cisplatin 20 mg/kg/intraperitoneal | C57BL/6 Mice and Mouse renal tubular epithelial cells (mTECs) | Herbal | (Fan et al., | |
|
Kaempferol 50, 100, 150 and 200 mg/kg for 2 weeks/oral | Flavonoid |
Nrf2; HO‐1; TBARS; iNOS; GSH; SOD; CAT; GR; GST; NQO‐1; Caspase‐3; Caspase‐9; Bax; Bcl‐2; TP53; PARP; IL‐12; TNF‐α; MPO p38; Phosphorylated‐JNK; JNK phosphorylated‐p38; p38 Phosphorylated‐ERK1/2 |
Cisplatin 20 mg/kg/intraperitoneal | Balb/C mice | Herbal | (Wang et al., | ||
|
|
Lycopene 6 mg kg−1 day−1 for 10 days/oral | Carotenoid | Nrf2; HO‐1; β‐Actin; CAT; GPx; SOD; NF‐κB |
Cisplatin 7 mg kg−1 day−1 for 10 day/intraperitoneal | Wistar rats | Herbal | (Sahin et al., | |
|
|
Mangiferin 5–30 µM/oral | Flavonoid | NDH; SDH; IL‐1β; TNFα; IL‐6; IL‐10; NF‐κB; Bax; Bcl‐2; Caspase‐3; Calpain; Caspase‐12; Nrf2; HO‐1; SOD‐2 |
Cisplatin 2, 5, 10, 15, 20, 25, 30, 40, and 50 µM in a serum‐free medium/oral | Swiss mice and Normal kidney epithelial (NKE) cell | Herbal | (Sadhukhan et al., | |
|
|
Piceatannol 10 mg kg−1 day−1 for 7 days/intraperitoneal | Hydroxylated analog of resveratrol | GCLC; GCLM; GST; HO‐1; KIM‐1; NGAL; Nrf2; NF‐κB; OCT‐2 |
Cisplatin 7 mg/kg/intraperitoneal | Wistar rats | Herbal | (Wahdan et al., | |
|
|
S‐allylcysteine 6.25, 12.5, 15, 20, 25, 50, 100, 150 and 200 mg/kg On day 1 and 2, two doses On days 3 and 4, a single dose/intraperitoneal | MDA; Oxidized proteins; GSH; Nrf2; PKCβ2; p47phox; gp91phox; CAT; GPx; GR |
Cisplatin 7.5 mg/kg/intraperitoneal | Wistar rats | Herbal | (Gõmez‐Sierra et al., | ||
|
| Ethanolic |
Schisandrin 500 mg kg−1 day−1 Wuzhi tablet which contains 7.5 mg Schisantherin A per tablet for 10 days/intraperitoneal | NQO‐1; HO‐1; GCLC; GCLC; GSH; MDA; Nrf2; SOD |
Cisplatin 15 mg/kg/intraperitoneal | NIH mice | Herbal | (J. Jin et al., | |
|
|
Tetramethylpyrazine 50 and 100 mg kg−1 day−1 for 2 weeks/intraperitoneal | Bax; Bcl‐2; HMGB‐1; PPAR‐γ; KIM‐1; TLR4; Caspase‐3; Nrf2; HO‐1; NQO‐1; TNF‐α; IL‐1β; ATP |
Cisplatin 7 mg/kg/intraperitoneal | Sprague–Dawley rats | Herbal | (Michel & Menze, | ||
|
Sinapic acid 20 mg/kg/for 10 days/oral | SOD level; Catalase activity; GSH; Nitric Oxide; lipid peroxidation MDA; total protein; TNF‐α; IL‐6; MPO; NF‐kB [p65]; Caspase; Bax 3; Bcl2; NRF2; HO‐1 |
Cisplatin 7 mg/kg/intraperitoneal | Wistar rats | Herbal | (Ansari, | |||
|
|
Xanthohumol 12.5, 25, 50 mg kg−1 day−1 for 3 days/intraperitoneal | Flavonoid | Nrf2; HO‐1; MDA; SOD; GSH; DCFH‐DA; DCF; TNF‐α; IL‐1ß; IL‐6; TLR4; NF‐κB; IκBα |
Cisplatin 20 mg/kg/intraperitoneal | C57BL/6 mice | Herbal | (Li et al., | |
|
Lycopene 5 and 20 mg kg−1 day−1 for 7 days/oral | Carotenoid | MDA; NO; iNOS; CAT; GSH; SOD; Caspase‐3; Caspase‐9; HO‐1; Nrf2; NF‐κB |
Colistin 15 mg kg−1 day−1 for 7 day/intravenous | Mice | Herbal | (Dai et al., | ||
|
| Ethanolic | 100, 150 and 200 mg kg−1 day−1 for 15 days/oral | Phenol | Bax; Bcl‐2; Caspase‐3; NF‐κB; NRF2; HMOX1; NQO‐1; Actb; MDA; Protein carbonyl; NO; GSH; SOD; CAT; GPx; TNF‐α; IL‐1ß | Cyclophosphamide 150 mg/kg/intraperitoneal | Wistar rats | Herbal | (Alhaithloul et al., |
|
Oleanolic acid 25 mg kg−1 day−1 for 7 days/intraperitoneal | Pentacyclic triterpenoid | Caspase‐3; α‐SMA; Nrf2; Keap1; HO‐1; NQO‐1; Bax; Bcl‐2; β‐Actin; SOD1; SOD2; CAT; MDA; 8‐iso‐PGF2α8‐OHdG |
Cyclosporine 30 mg kg−1 day−1 For 4 weeks/subcutaneous injection | ICR mice | Herbal | (Hong et al., | ||
|
| Ethanolic | 54,108 and 216 mg/kg/oral | MDA; CAT; GSH‐Px; Creatinine; BUN; P‐gp; Nrf2; HO‐1; GAPDH |
Cyclosporine 25 mg/kg/oral | Sprague–Dawley rats | Herbal | (Lai et al., | |
|
|
Paeonol 30 mg kg−1 day−1 for 4 days/intragastrical | SCR; GSH; GR; GST; CAT; SOD; NO; iNOS; TNF‐α; IL‐6; Cyt c oxidase; Caspase‐9; Caspase‐3; Bax; Bcl‐2; Nrf2; HO‐1; p‐NF‐κB; p‐IKKα/β; IκBα |
Epirubicin 15 mg/kg/intravenous injection | Balb/c mice | Herbal | (Wu et al., | ||
|
| 37 g/kg/ for 8 days/oral | Polyphenols | Nrf2; NF‐kB; Na+; K+ |
Gentamicin 100 mg kg−1 day−1 For 8 weeks/intraperitoneal | Albino mice | Herbal | (Y. I. Mahmoud, | |
|
| Ethyl acetate |
Pinocembrin 50 and 75 mg kg−1 day−1 for 10 days/intraperitoneal | Flavonoids | Bax; Bcl‐xl; Caspase‐3; Nrf2; HO‐1; NQO‐1; PKCα; NOX4; MDA; SOD; Oat3; [3H]ES uptake |
Gentamicin 100 mg kg−1 day−1 For 10 days/intraperitoneal | Sprague–Dawley rats | Herbal | (Promsan et al., |
|
| Methanolic | 250, 500 or 1,000 mg kg−1 day−1 for 15 days/oral | Anthocyanins, β‐carotene, γ‐oryzanol, and vitamin E complex | [3 H]ES uptake; Oat3; PKC α; Nrf2; Keap 1; NQO‐1; HO‐1 |
Gentamicin 100 mg kg−1 day−1 For 15 days/intraperitoneal | Sprague–Dawley rats | Herbal | (Arjinajarn et al., |
|
Berberine 50 mg/kg/day for 10 days/oral | Alkaloid | Nrf2; Keap1; P38; MAPK; NFκB; β‐actin; NF‐κB; TBPS; GSH; SOD; NO; Bax; Bcl‐xl; Caspase‐3; Caco‐2; HepG2; Mcf‐7 |
Methotrexate 20 mg/kg/intraperitoneal | Albino rats | Herbal | (Hassanein et al., | ||
|
|
Chicoric acid 25 and 50 mg kg−1 day−1 for 15 days/oral gavage | Dicaffeyltartaric acid | NRF2; NQO‐1; HO‐1; Bax; Bcl‐2; β‐actin; KIM‐1; ROS; MDA; NO; TNF‐α; GSH; SOD; CAT; GPx; NF‐κB; NF‐κB p65; Caspase‐3; NLRP3; Caspase‐1 p20; IL‐1β |
Methotrexate 20 mg/kg/intraperitoneal | Wistar rats | Herbal | (Abd El‐Twab et al., | |
|
| Ethanolic | 125 and 250 mg kg−1 day−1 for 15 days/oral | Nrf2; NQO‐1; HO‐1; SOD; CAT; GPx; Bax; Bcl‐2; GSH; GPx; NF‐κB; TNF‐α; IL‐1β |
Methotrexate 20 mg/kg/intraperitoneal | Wistar rats | Herbal | (A. M. Mahmoud et al., | |
|
Ferulic acid 25 and 50 mg kg−1 day−1 for 15 days/oral | Hydroxycinnamic acid | Nrf2; NQO‐1; HO‐1; PPARγ; Bax; Bcl‐2; ROS; MDA; NO; SOD; CAT; GPx; Caspase‐3; NLRP3; Caspase‐1 p20; IL‐1β; NF‐κB p65; Cytochrome c |
Methotrexate 20 mg/kg/intraperitoneal | Wistar rats | Herbal | (A. M. Mahmoud, Hussein, et al., | ||
|
|
18β‐Glycyrrhetinic acid 50 and 100 mg kg−1 day−1 for 7 days/oral | Triterpene | Nrf2; HO‐1; NO; TNF‐α; GSH; SOD; GPx; CST; Bax; Bcl‐2; β‐actin; KIM‐1 |
Methotrexate 20 mg/kg/intraperitoneal | Wistar rats | Herbal | (Abd El‐Twab et al., | |
|
|
Formononetin 10, 20, and 40 mg kg−1 day−1 for 10 days/oral | Isoflavone | NF‐κB; IL‐1β; IL‐6; TNF‐α; COX‐II; Nrf2; HO‐1; GSH; GR; GST; CAT; SOD; MDA; LPO; TBARS; 8‐Oxo‐dG; NO; ATP; Caspase‐3; Caspase‐9; Cell viability |
Methotrexate 20 mg/kg/at day 7/intraperitoneal | Wistar rats and HepG2 cells | Herbal | (Aladaileh et al., | |
|
Vincamine 10, 20 and 40 mg/kg/oral | Alkaloid | Nrf2; HO‐1; MDA; SOD; CAT; NF‐κB; IL‐1β; IL‐10; TNF‐α; MPO; COX‐II; Caspase‐3 |
Methotrexate 20 mg/kg/intraperitoneal | Sprague–Dawley rats | Herbal | (Shalaby et al., | ||
|
|
Diallyl trisulfide 20, 40 and 80 mg/kg/day for 28 days/oral | Polysulfide | RBC; WBC; TBARS; LOOH; PC; ROS; NO; SOD; CAT; GPx; GST; GR; G6PD; GSH; T‐SH; Vitamin C; Vitamin E; Total ATPaseNa+/K+ ATPase; Ca2+ ATPase; Mg2+ ATPase |
Arsenic 5 mg kg−1 day−1 for 4 weeks/intragastrically | albino rats | Herbal | (Miltonprabu et al., | |
|
|
Sulforaphane 80 mg kg−1 day−1 for 28 days/oral | Isothiocyanate | GSH; total sulphydryl; Vitamin C; Vitamin E; SOD; CAT; GPx; GST; GR |
Arsenic 5 mg kg−1 day−1 for 28 day/oral | Wistar rats | Herbal | (Thangapandiyan et al., | |
|
Tannic acid 20 and 40 mg kg−1 day−1 for 10 days/oral | Polyphenol | CREA; CAT; GSH‐Px; SOD; MDA; GSH; total sulphydryl; GST; GR; G6PDH; LOOH; PC; CD; IL‐6; IL‐8TNF‐α; Bcl‐2; Bcl‐xl; p53; Bax; NF‐κB p65; Nrf2; Keap1 |
Arsenic 5 mg kg−1 day−1/intraperitoneal | Rats | Herbal | (W. Jin et al., | ||
|
Lycopene 5 mg/kg/ for 21 days/oral | Carotenoid | T‐AOC; T‐SOD; MDA; GSH; GSH‐Px; GSH‐ST; H2O2; CAT; Nrf2; NQO‐1; HO‐1; ATGs; Beclin‐1; LC3II/LC3I ratio; AKT1; MAPK1 p62/SQSTM; AMPK; p‐AMPK protein; |
Atrazine 50 mg/kg and 200 mg/kg/ for 21 days/oral | Mice | Herbal | (J. Lin, Xia, et al., | ||
|
|
Carnosic acid 10 mg kg−1 day−1/oral | Diterpene | Cell viability; GSH; SOD; CAT; GPx; GST; GR; ROS; NO; H2O2; NADPH oxidase; TBARS; P‐Smad3; TGF‐β1; Smad7; Nrf2; Keap1; Cullin3; Ubiquitin; HO‐1; Collagen IV; Bcl‐2; Caspase‐3; Caspase‐8; Caspase‐9; IL‐6; IL‐1β; TNF‐α |
Cadmium 4 mg kg−1 day−1/oral | Normal Kidney Epithelial (NKE) Cells and Mice | Herbal | (Das et al., | |
|
| Aqueous |
Proanthocyanidin 100 mg kg−1 day−1 for 4 weeks/oral | Flavonoid | GSH; total sulphydryl; Vitamin C; Vitamin E; SOD; CAT; GPx; GST; GR; G6PD; iNOS; Caspase‐3; Total ATPases; Na+/K+ ATPase; Ca2+ ATPase; Mg2+ ATPase; TNF‐α; NO; IL‐6; IL‐1β; NF‐κB p65; LOOH; PCC |
Cadmium 5 mg kg−1 day−1 for 4 weeks/oral | Wistar rats | Herbal | (Nazima et al., |
|
Resveratrol 400 mg/kg for 90 days/oral | Polyphenolic | T‐SOD; Cu‐Zn SOD; GSH‐Px; GST; CAT; T‐AOC; H2O2; MDA; CYP450; Cyt‐b5; APND; ERND; AH; NCR; Nrf2; SOD2; Sirt1; PGC‐1α; TFAM; Sirt3; PRDX3; VDAC1; Cyt C |
Cadmium 140 mg/kg/oral | Chicken | Herbal | (Q. Zhang et al., | ||
|
Tangeretin 50 mg kg−1 day−1/oral | Flavonoid | Nrf2; Keap1; NQO‐1; HO‐1; NF‐κB; TNF‐a; IL‐1β; IL‐6; NF‐κB/p65; GAPDH; AST; ALT; ALP; Lipid peroxides Hydroperoxides; Protein carbonyls; Vitamin C; Vitamin E; GSH |
7,12‐Dimethylbenz[a] anthracene 25 mg/kg/inhalation | Wistar rats | Herbal | (Lakshmi & Subramanian, | ||
|
Luteolin 50 mg/kg/oral | Flavonoid | SOD2; CAT; GPX1; GSR; NFE2L2; HMOX1; TNF‐a; IL‐1β; IL‐6; NOS2; Caspase‐3; Bax; Bcl‐2; LPO |
Lead acetate 20 mg/kg/intraperitoneal | Rats | Herbal | (Albarakati et al., | ||
|
| Methanolic | 300 mg/kg for 28 days/oral | SOD2; GSR; NFE2L2; HMOX1; TNF‐a; IL‐1β; IL‐6; NOS2; Casp3; Bax; Bcl‐2; LPO; MDA; NO; GSH; CAT; GPx; GST; GR; NQO‐1; KIM‐1 |
Mercury chloride 0.4 mg/kg/intraperitoneal | Wistar rats | Herbal | (Almeer et al., | |
|
| Cycloartenyl ferulate | Triterpene alcohol | Nrf2; HO‐1; NQO‐1; ROS; Superoxide; Bax; Bcl‐2; Caspase activity; LDH; PARP; Cell viability | Paraquat | Proximal tubular cell line derived from normal human kidney | Herbal | (G. L. Hong et al., | |
|
| Aqueous |
Epigallocatechin‐3‐gallate (EGCG) 25 μM | Polyphenol | Cell viability; E‐cadherin; Occludin; ZO‐1; Cytokeratin; Vimentin; Fibronectin; Nrf2; CAT |
Oxalate 0.5 mM For 24 hr | MDCK renal tubular cells | Herbal | (Kanlaya et al., |
|
Mangiferin 20 mM | Cell viability; Nrf2; LDH; FRAP; MDA; GSH; GSSG; CAT; SOD; GPx; GST; GR; Caspase‐8; tBid; Bax; Cytochrome C; Apaf‐1; Caspase‐9; Caspase‐3; PARP |
Tert‐butyl hydroperoxide 50 mM t‐BHP for 18 hr | Normal human kidney epithelial cells | Herbal | (Saha et al., | |||
|
Rutin 16.3–1.63 µM for 1 hr | Flavonoid | MDA; −CO; GSH; −SH levels; ROS; CAT; SOD; GPx; GST; GR; Nrf2; i;NOS |
Tert‐butyl hydroperoxide 10 µM For 1 hr | Erythrocytes | Herbal | (Singh et al., | ||
|
| Ethanolic | 400 mg kg−1 day−1 for 2 mounts | Phenol | Nrf2; KIM‐1; HO‐1; TNF‐α; NF‐кB; HSP70; SOD; GST; GSH; GPx; Total thiols; MDA |
Titanium dioxide 500 mg/kg | Albino rats | Herbal | (Abdou et al., |